Stifel Nicolaus analyst Brian Brophy maintained a Hold rating on Custom Truck One Source (CTOS – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday ...
For CTOs and CIOs, understanding the Act's implications is essential to navigating the impact on innovation and compliance. At its core, the Act defines the red lines for AI use in the EU.
PETALING JAYA: CTOS Digital Bhd ’s prospects remain robust despite its management’s cautious stance on internal targets for this year. This is underpinned by the company’s diversified ...
KANSAS CITY, Mo., March 07, 2025--Custom Truck One Source, Inc. (NYSE: CTOS), a leading provider of specialty equipment to the electric utility, telecom, rail, and other infrastructure-related end ...
In this article, we are going to take a look at where Custom Truck One Source, Inc. (NYSE:CTOS) stands against other penny stocks with insider buying in 2025. Insider trading can be a reliable ...
In a report released today, Michael Shlisky from D.A. Davidson reiterated a Buy rating on Custom Truck One Source (CTOS – Research Report), with a price target of $9.00. The company’s shares ...
Additionally, in January of this year, we and Platinum Equity jointly purchased all of Energy Capital Partners' remaining CTOS shares at a price of $4 per share. We felt it was an attractive ...
Custom Truck One Source, Inc. (CTOS) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.07 per share a year ago.
While some organizations continue to appoint dedicated AI leaders, we’re increasingly seeing AI responsibilities being embedded within existing C-suite roles – including CDOs, CIOs, and CTOs – ...
In this article, we are going to take a look at where Custom Truck One Source, Inc. (NYSE:CTOS) stands against other stocks with at least $20 million in insider spending recently. As the stock ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...